These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19146938)

  • 1. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease.
    Tabuchi M; Yamaguchi T; Iizuka S; Imamura S; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2009 Feb; 122(1):157-62. PubMed ID: 19146938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
    Zhang L; Xing Y; Ye CF; Ai HX; Wei HF; Li L
    Behav Brain Res; 2006 Oct; 173(2):246-54. PubMed ID: 16901557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
    Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
    Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
    Rustay NR; Cronin EA; Curzon P; Markosyan S; Bitner RS; Ellis TA; Waring JF; Decker MW; Rueter LE; Browman KE
    Brain Res; 2010 Jan; 1311():136-47. PubMed ID: 19944081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease.
    Subash S; Braidy N; Essa MM; Zayana AB; Ragini V; Al-Adawi S; Al-Asmi A; Guillemin GJ
    Nutrition; 2015 Jan; 31(1):223-9. PubMed ID: 25441596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Abeta-bearing fragment is associated with reduced NMDA receptor density.
    Boon WC; van den Buuse M; Wegener N; Martin S; Chua HK; Bush AI; Masters CL; Adlard PA; Li QX
    Behav Brain Res; 2010 May; 209(1):27-35. PubMed ID: 20085783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
    Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
    J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
    J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic effects of Salvia reuterana Boiss. on the elevated plus-maze model of anxiety in mice.
    Rabbani M; Sajjadi SE; Jafarian A; Vaseghi G
    J Ethnopharmacol; 2005 Oct; 101(1-3):100-3. PubMed ID: 15994042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
    Zhuo JM; Prescott SL; Murray ME; Zhang HY; Baxter MG; Nicolle MM
    Neurobiol Aging; 2007 Aug; 28(8):1248-57. PubMed ID: 16828204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
    Augustin S; Rimbach G; Augustin K; Schliebs R; Wolffram S; Cermak R
    Arch Biochem Biophys; 2009 Jan; 481(2):177-82. PubMed ID: 18996078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice.
    Le Cudennec C; Faure A; Ly M; Delatour B
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():83-91. PubMed ID: 18184372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.